about
Epigenetic control of HIV-1 post integration latency: implications for therapyEffects of treatment with suppressive combination antiretroviral drug therapy and the histone deacetylase inhibitor suberoylanilide hydroxamic acid; (SAHA) on SIV-infected Chinese rhesus macaquesControlling the HIV/AIDS epidemic: current status and global challengesMechanisms of HIV Transcriptional Regulation by Drugs of Abuse.Dissecting the mechanism of histone deacetylase inhibitors to enhance the activity of zinc finger nucleases delivered by integrase-defective lentiviral vectors.HIV-1 expression within resting CD4+ T cells after multiple doses of vorinostatAdministration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapySnapshots: chromatin control of viral infection.Tissue myeloid cells in SIV-infected primates acquire viral DNA through phagocytosis of infected T cells.Interaction between endogenous bacterial flora and latent HIV infection.HIV-1 Tat upregulates expression of histone deacetylase-2 (HDAC2) in human neurons: implication for HIV-associated neurocognitive disorder (HAND).Simian Immunodeficiency Virus SIVsab Infection of Rhesus Macaques as a Model of Complete Immunological Suppression with Persistent Reservoirs of Replication-Competent Virus: Implications for Cure Research.Reactivation of Latent HIV-1 Expression by Engineered TALE Transcription Factors.The future of HIV treatment.Amino acid starvation induces reactivation of silenced transgenes and latent HIV-1 provirus via down-regulation of histone deacetylase 4 (HDAC4)BIRC2/cIAP1 Is a Negative Regulator of HIV-1 Transcription and Can Be Targeted by Smac Mimetics to Promote Reversal of Viral Latency.Synergistic Activation of Latent HIV-1 Expression by Novel Histone Deacetylase Inhibitors and Bryostatin-1.Human immunodeficiency virus (HIV) latency: the major hurdle in HIV eradicationDevelopment of NanoART for HIV Treatment: Minding the Cytochrome P450 (CYP) EnzymesA Novel Class of HIV-1 Antiviral Agents Targeting HIV via a SUMOylation-Dependent Mechanism.Effect of histone deacetylase inhibitors on HIV production in latently infected, resting CD4(+) T cells from infected individuals receiving effective antiretroviral therapyPharmacologic reactivation of latent feline immunodeficiency virus ex vivo in peripheral CD4+ T-lymphocytes.Verotoxin A subunit protects lymphocytes and T cell lines against X4 HIV infection in vitro.Development of 5' LTR DNA methylation of latent HIV-1 provirus in cell line models and in long-term-infected individualsViral latency and potential eradication of HIV-1.Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantationThe effects of cocaine on HIV transcriptionHIV-1 transcription and latency: an update.Immunological and pharmacological strategies to reactivate HIV-1 from latently infected cells: a possibility for HIV-1 paediatric patients?Deployment of the human immunodeficiency virus type 1 protein arsenal: combating the host to enhance viral transcription and providing targets for therapeutic developmentSIV replication is directly downregulated by four antiviral miRNAs.HIV infection: what should be considered in approaches for a cure?An HIV-1 replication pathway utilizing reverse transcription products that fail to integrate.Unique characteristics of histone deacetylase inhibitors in reactivation of latent HIV-1 in Bcl-2-transduced primary resting CD4+ T cellsPharmacokinetics and pharmacodynamics of suberoylanilide hydroxamic acid in cats.Epigenetic regulation of HIV-1 latency in astrocytesAchieving a cure for HIV infection: do we have reasons to be optimistic?Eliminating the HIV reservoir.Developing strategies for HIV-1 eradicationFeline immunodeficiency virus latency.
P2860
Q26781191-76E4A2B5-F677-4218-BC3F-1281B3AFFADFQ28540858-C51E6830-E278-46B0-94D4-492DE50D15B3Q30420558-B2EBB055-9C0E-4B82-AD8A-7B830BB7861DQ33815611-3F435950-B9E2-4A7E-815A-E90A00DA457EQ33903876-7F28B3F6-46BD-414F-B38B-92B771D4A98BQ34106191-7953A329-CCA8-4168-BF72-C99DC19C6E14Q34290545-757F0FAE-4ECB-4DAC-87A3-E78A20CD9770Q34315920-65568752-3B5A-4079-9FA3-F59C167AA9C4Q34561884-3672E70B-59D1-4495-8118-A01453B8F558Q34686713-B45F40B9-097C-4277-AB51-9F18F1813A24Q34903986-BC634D88-CBA8-4F7D-926B-D53D83CD26EDQ35641175-7D75967C-015D-4EC0-B245-512334666A3EQ35942658-CDFC2F84-FDC3-4D9A-BEC9-A2D324E84C9BQ36115687-B6668936-7D61-4C91-AD53-BE185C9B11ABQ36187278-3E28BAEE-2104-4A0B-B3AC-B57BEDDE1133Q36198250-589C7C51-71F8-4F43-A121-94D3DB388E51Q36275685-F2DC7A74-95DA-4FA6-9378-2825FBCBAEA7Q36330062-AC4D8C91-6CE5-47B5-A057-2C5024451E0CQ36338109-69ED1AF8-0CB7-485E-8E1F-8D09819EC49FQ36353497-68702446-6815-4CFA-8E88-8C1CF63BBE27Q36379282-9DECCE6F-059F-4467-9682-40D7D98AA320Q36442846-04E23670-0332-4BB1-90D6-68F6A0995315Q36482722-DA46F9DF-2DA8-49BD-99CE-776866F7C6F9Q36596027-09AF65B5-CF9A-4E78-A7DB-BDEF77C34ECFQ36613690-9661F11D-1053-473B-B002-62C917DCEA4AQ36796554-DFE2CAAD-8F1C-4C31-B878-ECCC55E438F6Q36906001-BCF09F01-C308-42AE-95F3-29306A47AF7CQ36976156-EE8A6793-5B00-40DB-B363-DB9D337EEEA3Q37098356-2C35AD34-B67E-40D4-8917-8151B8A03DFBQ37127522-2F9A3E78-D44A-4DC4-9BF5-5E42209DC761Q37155048-982815B3-23B6-4290-BB0E-FD363B470D82Q37329003-BDBD0488-3D53-4A9B-A10E-8A5EAC5C9926Q37336473-B661621B-D9F2-4A23-BADD-A9FF06A7DCB8Q37388295-B519E46A-768E-4B4E-84E8-BE95BA6D2E49Q37629416-FB2BC7CD-C11F-4E8F-AEE7-108FE4D07BB0Q37643982-8E636CBF-A38E-45AD-811F-AE1E1199AAD7Q37980423-C86C13AC-0A50-4245-B49C-890FF118FD9BQ37993454-FA9FA194-E909-44DC-9BEF-9A87377CCD64Q38032363-0122787A-82D9-4E9C-BDC1-EC7EBE8AD3CFQ38119498-8B5625E0-1ECA-4085-83CB-93D9D92966FC
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Histone deacetylase inhibitors and HIV latency.
@ast
Histone deacetylase inhibitors and HIV latency.
@en
Histone deacetylase inhibitors and HIV latency.
@nl
type
label
Histone deacetylase inhibitors and HIV latency.
@ast
Histone deacetylase inhibitors and HIV latency.
@en
Histone deacetylase inhibitors and HIV latency.
@nl
prefLabel
Histone deacetylase inhibitors and HIV latency.
@ast
Histone deacetylase inhibitors and HIV latency.
@en
Histone deacetylase inhibitors and HIV latency.
@nl
P2860
P1476
Histone deacetylase inhibitors and HIV latency.
@en
P2860
P356
10.1097/COH.0B013E328341242D
P577
2011-01-01T00:00:00Z